|
Abbreviated name: TSLP
Compound class:
Endogenous peptide in human, mouse or rat
Comment: Thymic stromal lymphopoietin (TLSP), an IL-7 like cytokine, is the endogenous ligand for the TLSP receptor. TLSP/TLSPR signalling is pro-inflammatory.
Species: Human
|
| Immunopharmacology Comments |
| TLSP/TLSPR signalling promotes release of pro-inflammatory Th2 mediators by mast cells and eosinophils [5], enhances eosinophil chemotaxis and pro-survival properties [9], and modulates mast cell proliferation and differentiation from progenitors [4]. TLSP is elevated in patients with severe asthma [8] and atopic dermatitis [7]. Anti-TSLP agents offer potential for the treatment of a variety of inflammatory conditions [2]. For example, the anti-TLSP mAb, tezepelumab (a.k.a. AMG 157 or MEDI9929), has completed Phase 1 evaluation in atopic dermatitis [3] (see NCT00757042) and Phase 2 for asthma (NCT02054130). |